Connect with us

INDUSTRIAL HEMP

Cara Therapeutics Inc (NASDAQ:CARA) Records Progress With Pruritus Program In Q3 2017

Published

on

Cara Therapeutics Inc (NASDAQ:CARA) issued its financial report for the third quarter closed September 30, 2017. Derek Chalmers, Ph.D., D.Sc., the CEO and President, expressed that they are particularly delighted with the progress recorded in their pruritus program in Q3 2017, including successful completion of company’s end-of-Phase II talks with the FDA, supporting their plan to commence first pivotal Phase III efficacy study of I.V. CR845 targeting CKD-aP in hemodialysis patients in the United States by the close of 2017.

The highlights

The CEO of Cara added that they recently commenced a Phase I trial of Oral CR845 in subjects with Stage 3-V CKD which will inform design and dose selection of company’s planned Phase 2 study in this subject population for early in 2018. They consider that CR845 holds the potential to offer meaningful benefit to a range of people suffering from pruritus, including patients with different stages of CKD and those with chronic liver disease. Additionally, they continue towards full registration in the underway Phase 3 study with I.V. CR845 targeting acute post-operative pain in people undergoing abdominal surgery.

Cara posted a net loss of $12.4 million in the third quarter of 2017 versus a net loss of $11.5 million, in the comparable period of 2016. It did not record any revenue during Q3 2017 as well as in Q3 2016. R&D expenses came at $9.2 million in the reported quarter of 2017 versus $9.7 million in the comparable period of 2016. The lower R&D expenses were mainly due to a net drop in direct clinical study costs, partially offset by jump in personnel-related costs and stock-based compensation.

Cara posted G&A expenses of $3.8 million in Q3 2017 as against $2.1 million in the comparable period of 2016. The increased G&A expenses can be attributed to increases in personnel-related costs, professional fees and stock-based compensation.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized1 day ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health2 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business2 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business2 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business2 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP2 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP2 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP2 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

INDUSTRIAL HEMP2 weeks ago

Kush Bottles Inc (OTCMKTS:KSHB)’ Q1 Results For Fiscal Year 2018 Released

Leading supplier and service provider to the cannabis sector, Kush Bottles Inc (OTCMKTS:KSHB), has released financial results for 2018’s first...

INDUSTRIAL HEMP2 weeks ago

Wanderport Corp. (OTCMKTS:WDRP) Will Accept The Use Of Bitcoin In Its E-Commerce Store

Wanderport Corp. (OTCMKTS:WDRP) has made good its promise of allowing full access to the Company’s full suite of products. The...

Advertisement
Advertisement